Full Text View
Tabular View
Study Results
Related Studies
Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder.
This study has been completed.
Study NCT00561951   Information provided by Pfizer

First Received on November 19, 2007.   Last Updated on July 11, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial